使用混合聚合物微粒体降解率优化多价位子单位流感疫苗的输送
Erik S Pena1, Luis Ontiveros-Padilla2, Nicole R Lukesh2
1Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA.
概括
这项研究开发了一种新的多价值流感疫苗,使用乙化微粒 (Ace-DEX MPs) 封装抗原和辅助剂. 优化微粒子降解率提高了免疫反应,并提供了对流感菌株的广泛保护.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 季节性流感疫苗的有效性各不相同,新型流感病毒像H5N1这样的新型病毒构成重大威胁.
- 广泛作用的疫苗需要辅助剂和先进的输送系统来增强免疫性,剂量节约性和热稳定性.
- 乙化德克斯微粒 (Ace-DEX MPs) 被探索为改善疫苗性能的交付平台.
研究的目的:
- 为了研究乙化德克斯微粒 (Ace-DEX MPs) 封装cGAMP (辅助剂) 和计算优化广泛反应抗原 (COBRA) 血凝素 (HA) 用于多价值流感疫苗.
- 评估混合Ace-DEXMPs与不同降解速率对免疫反应的影响.
- 在动物模型中评估开发的疫苗对流感菌株的保护效果.
主要方法:
- 用于封装cGAMP和COBRA HA蛋白质的Ace-DEXMPs的配方.
- 用不同降解动力学 (快速,缓慢或混合) 的Ace-DEX MPs接种小鼠疫苗.
- 对小鼠免疫反应 (IgG2a标位,细胞因子产生) 的评估以及对子流感的保护研究.
主要成果:
- 降解速度较慢的cGAMP MPs诱导了更高的IgG2a标位和IL-2的产生.
- 快速和缓慢降解的cGAMPMP混合物最大限度地提高了小鼠的IFN-γ产量.
- 一种含有缓慢降解cGAMP MPs的三价COBRA配方在中提供了对H1,H3和H5菌株的保护.
- 具有差异性降解率的抗原的同时递送降低了单抗原的主导地位.
结论:
- 艾斯-德克斯国会议员是开发有效多价值流感疫苗的多功能平台.
- 微粒子降解动力学显著影响免疫反应的类型和程度.
- 这种方法有可能提高疫苗的疗效,节省剂量,以及针对不同流感菌株的热稳定性.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:20Modified-Release Drug Delivery Systems: Influencing Factors
208
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
208
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:23Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144